{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:21:46Z","timestamp":1747207306814,"version":"3.40.5"},"reference-count":41,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDT"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Melanocortins are tiny protein molecules formed by the post-translational cleavage of proopiomelanocortin. These are bioactive peptides that are responsible for human and lower animal pigmentation patterns, energy homeostasis, and sexual function modulation. These peptides regulate numerous physiological functions by being generated in the central nervous system and peripheral tissues. Melanocortins elicit their varied biological effects by binding to a separate family of G protein, two primary proteolytic enzymes, proconvertases 1 and 2, according to recent research. These breakthroughs have opened up new avenues for research into the role of melanocortins, antagonists, and receptors in a number of physiological activities.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389450124666221108143006","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T06:08:31Z","timestamp":1668146911000},"page":"151-156","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Melanocortin Receptors: Emerging Targets for the Treatment of Pigmentation,\nInflammation, Stress, Weight Disorders and Sexual Dysfunction"],"prefix":"10.2174","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6328-4731","authenticated-orcid":true,"given":"Miteshkumar Rajaram","family":"Maurya","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacology, Topiwala National Medical College and BYL Nair Charitable Hospital, AL Nair road, Mumbai-400008, Mumbai, Maharashtra, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9637-6891","authenticated-orcid":true,"given":"Renuka","family":"Munshi","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Topiwala National Medical College and BYL Nair Charitable Hospital, AL Nair road, Mumbai-400008, Mumbai, Maharashtra, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachin","family":"Zambare","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Sterling Hospital, Vadodara, Gujarat, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3389\/fendo.2013.00143","volume":"4","author":"Takahashi A.","year":"2013","unstructured":"Takahashi A.; Mizusawa K.; Posttranslational modifications of proopiomelanocortin in vertebrates and their biological significance. Front Endocrinol 2013,4,143","journal-title":"Front Endocrinol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"E1039","DOI":"10.1152\/ajpendo.00238.2003","volume":"285","author":"Vazquez-Martinez R.","year":"2003","unstructured":"Vazquez-Martinez R.; Casta&#xF1;o J.P.; Tonon M.C.; Vaudry H.; Gracia-Navarro F.; Malagon M.M.; Melanotrope secretory cycle is regulated by physiological inputs via the hypothalamus. Am J Physiol Endocrinol Metab 2003,285(5),E1039-E1046","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref=3a","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s13353-013-0163-z","volume":"54","author":"Switonski M.","year":"2013","unstructured":"Switonski M.; Mankowska M.; Salamon S.; Family of melanocortin receptor (MCR) genes in mammals-mutations, polymorphisms and phenotypic effects. J Appl Genet 2013,54(4),461-472","journal-title":"J Appl Genet"},{"key":"ref=3b","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fendo.2012.00009","volume":"3","author":"Kobayashi Y.","year":"2012","unstructured":"Kobayashi Y.; Mizusawa K.; Saito Y.; Takahashi A.; Melanocortin systems on pigment dispersion in fish chromatophores. Front Endocrinol 2012,3,9","journal-title":"Front Endocrinol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/pcmr.12040","volume":"26","author":"Nilsson Sk&#xF6;ld H.","year":"2013","unstructured":"Nilsson Sk&#xF6;ld H.; Aspengren S.; Wallin M.; Rapid color change in fish and amphibians - function, regulation, and emerging applications. Pigment Cell Melanoma Res 2013,26(1),29-38","journal-title":"Pigment Cell Melanoma Res"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S1043-2760(99)00213-1","volume":"11","author":"Krude H.","year":"2000","unstructured":"Krude H.; Gr&#xFC;ters A.; Implications of proopiomelanocortin (POMC) mutations in humans: the POMC deficiency syndrome. Trends Endocrinol Metab 2000,11(1),15-22","journal-title":"Trends Endocrinol Metab"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1210\/er.2011-1016","volume":"33","author":"B&#xF6;hm M.","year":"2012","unstructured":"B&#xF6;hm M.; Gr&#xE4;ssel S.; Role of proopiomelanocortin-derived peptides and their receptors in the osteoarticular system: from basic to translational research. Endocr Rev 2012,33(4),623-651","journal-title":"Endocr Rev"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1743-7075-4-18","volume":"4","author":"Millington G.W.M.","year":"2007","unstructured":"Millington G.W.M.; The role of proopiomelanocortin (POMC) neurones in feeding behaviour. Nutr Metab 2007,4(1),18","journal-title":"Nutr Metab"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nature05660","volume":"445","author":"Lin J.Y.","year":"2007","unstructured":"Lin J.Y.; Fisher D.E.; Melanocyte biology and skin pigmentation. Nature 2007,445(7130),843-850","journal-title":"Nature"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1590\/S0365-05962013000100009","volume":"88","author":"Videira I.F.S.","year":"2013","unstructured":"Videira I.F.S.; Moura D.F.L.; Magina S.; Mechanisms regulating melanogenesis. An Bras Dermatol 2013,88(1),76-83","journal-title":"An Bras Dermatol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1600-0781.2004.00132.x","volume":"20","author":"Healy E.","year":"2004","unstructured":"Healy E.; Melanocortin 1 receptor variants, pigmentation, and skin cancer susceptibility. Photodermatol Photoimmunol Photomed 2004,20(6),283-288","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/ng.2007.13","volume":"39","author":"Sulem P.","year":"2007","unstructured":"Sulem P.; Gudbjartsson D.F.; Stacey S.N.; Genetic determinants of hair, eye and skin pigmentation in Europeans. Nat Genet 2007,39(12),1443-1452","journal-title":"Nat Genet"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cbpa.2017.06.001","volume":"211","author":"Cal L.","year":"2017","unstructured":"Cal L.; Suarez-Bregua P.; Cerd&#xE1;-Reverter J.M.; Braasch I.; Rotllant J.; Fish pigmentation and the melanocortin system. Comp Biochem Physiol A Mol Integr Physiol 2017,211,26-33","journal-title":"Comp Biochem Physiol A Mol Integr Physiol"},{"key":"ref=13","first-page":"7: 95","author":"Wolf Horrell EM","year":"2016","unstructured":"Wolf Horrell EM; Boulanger MC; D\u2019Orazio JA; Melanocortin 1 receptor: Structure, function, and regulation. Front Genet 2016,7: 95"},{"key":"ref=13b","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ad.2011.08.002","volume":"103","author":"Mahiques-Santos L.","year":"2012","unstructured":"Mahiques-Santos L.; Melanotan. Actas Dermosifiliogr 2012,103(4),257-259","journal-title":"Actas Dermosifiliogr"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"b566","DOI":"10.1136\/bmj.b566","volume":"338","author":"Evans-Brown M.","year":"2009","unstructured":"Evans-Brown M.; Dawson R.T.; Chandler M.; McVeigh J.; Use of melanotan I and II in the general population. BMJ 2009,338(2),b566","journal-title":"BMJ"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/(SICI)1099-081X(199704)18:3<259:AID-BDD20>3.0.CO;2-X","volume":"18","author":"Ugwu S.O.","year":"1997","unstructured":"Ugwu S.O.; Blanchard J.; Dorr R.T.; Skin pigmentation and pharmacokinetics of melanotan-I in humans. Biopharm Drug Dispos 1997,18(3),259-269","journal-title":"Biopharm Drug Dispos"},{"key":"ref=16","doi-asserted-by":"publisher","DOI":"10.1016\/j.esxm.2020.100298","volume":"9","author":"Mallory C.W.","year":"2021","unstructured":"Mallory C.W.; Lopategui D.M.; Cordon B.H.; Melanotan tanning injection: A rare cause of priapism. Sex Med 2021,9(1)","journal-title":"Sex Med"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"R158","DOI":"10.1152\/ajpregu.00059.2014","volume":"307","author":"Monge-Roffarello B.","year":"2014","unstructured":"Monge-Roffarello B.; Labbe S.M.; Lenglos C.; The medial preoptic nucleus as a site of the thermogenic and metabolic actions of melanotan II in male rats. Am J Physiol Regul Integr Comp Physiol 2014,307(2),R158-R166","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0014-2999(99)00045-X","volume":"369","author":"Vergoni A.V.","year":"1999","unstructured":"Vergoni A.V.; Bertolini A.; Wikberg J.E.S.; Schi&#xF6;th H.B.; Selective melanocortin MC4 receptor blockage reduces immobilization stress-induced anorexia in rats. Eur J Pharmacol 1999,369(1),11-15","journal-title":"Eur J Pharmacol"},{"year":"2000","author":"Lim C.T.","key":"ref=19","unstructured":"Lim C.T.; Khoo B.; Normal physiology of ACTH and GH release in the hypothalamus and anterior pituitary in man. In: Endotext. South Dartmouth (MA): MDText.com, Inc. 2000"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3389\/fimmu.2011.00041","volume":"2","author":"Patel H.B.","year":"2011","unstructured":"Patel H.B.; Montero-Melendez T.; Greco K.V.; Perretti M.; Melanocortin receptors as novel effectors of macrophage responses in inflammation. Front Immunol 2011,2,41","journal-title":"Front Immunol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"R151","DOI":"10.1186\/ar2827","volume":"11","author":"Capsoni F.","year":"2009","unstructured":"Capsoni F.; Ongari A.M.; Reali E.; Catania A.; Melanocortin peptides inhibit urate crystal-induced activation of phagocytic cells. Arthritis Res Ther 2009,11(5),R151","journal-title":"Arthritis Res Ther"},{"key":"ref=22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071056","volume":"8","author":"Schaible E.V.","year":"2013","unstructured":"Schaible E.V.; Steinstr&#xE4;&#xDF;er A.; Jahn-Eimermacher A.; Single administration of tripeptide &#x3B1;-MSH(11-13) attenuates brain damage by reduced inflammation and apoptosis after experimental traumatic brain injury in mice. PLoS One 2013,8(8)","journal-title":"PLoS One"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"E468","DOI":"10.1152\/ajpendo.00434.2002","volume":"284","author":"Gantz I.","year":"2003","unstructured":"Gantz I.; Fong T.M.; The melanocortin system. Am J Physiol Endocrinol Metab 2003,284(3),E468-E474","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1189\/jlb.1204748","volume":"80","author":"Kang L.","year":"2006","unstructured":"Kang L.; McIntyre K.W.; Gillooly K.M.; A selective small molecule agonist of the melanocortin-1 receptor inhibits lipopolysaccharide-induced cytokine accumulation and leukocyte infiltration in mice. J Leukoc Biol 2006,80(4),897-904","journal-title":"J Leukoc Biol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1476-5381.2010.00688.x","volume":"160","author":"Leoni G.","year":"2010","unstructured":"Leoni G.; Voisin M-B.; Carlson K.; Getting S.J.; Nourshargh S.; Perretti M.; The melanocortin MC1 receptor agonist BMS-470539 inhibits leucocyte trafficking in the inflamed vasculature. Br J Pharmacol 2010,160(1),171-180","journal-title":"Br J Pharmacol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1002\/art.10526","volume":"46","author":"Getting S.J.","year":"2002","unstructured":"Getting S.J.; Christian H.C.; Flower R.J.; Perretti M.; Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis. Arthritis Rheum 2002,46(10),2765-2775","journal-title":"Arthritis Rheum"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.2174\/156802607780906618","volume":"7","author":"Taketoshi O.","year":"2007","unstructured":"Taketoshi O.; Shigeyuki C.; Melanocortin-4 receptor antagonists for the treatment of depression and anxiety disorders. Curr Top Med Chem 2007,7(11),1145-1151","journal-title":"Curr Top Med Chem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0014-2999(03)02033-8","volume":"474","author":"Chaki S.","year":"2003","unstructured":"Chaki S.; Ogawa S.; Toda Y.; Funakoshi T.; Okuyama S.; Involvement of the melanocortin MC4 receptor in stress-related behavior in rodents. Eur J Pharmacol 2003,474(1),95-101","journal-title":"Eur J Pharmacol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0014-2999(02)01989-1","volume":"450","author":"MacNeil D.J.","year":"2002","unstructured":"MacNeil D.J.; Howard A.D.; Guan X.; The role of melanocortins in body weight regulation: Opportunities for the treatment of obesity. Eur J Pharmacol 2002,450(1),93-109","journal-title":"Eur J Pharmacol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.molmed.2018.12.002","volume":"25","author":"K&#xFC;hnen P.","year":"2019","unstructured":"K&#xFC;hnen P.; Krude H.; Biebermann H.; Melanocortin-4 receptor signalling: Importance for weight regulation and obesity treatment. Trends Mol Med 2019,25(2),136-148","journal-title":"Trends Mol Med"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/JOE-18-0596","volume":"241","author":"Baldini G.","year":"2019","unstructured":"Baldini G.; Phelan K.D.; The melanocortin pathway and control of appetite-progress and therapeutic implications. J Endocrinol 2019,241(1),R1-R33","journal-title":"J Endocrinol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1210\/jc.2018-00258","volume":"103","author":"Ayers K.L.","year":"2018","unstructured":"Ayers K.L.; Glicksberg B.S.; Garfield A.S.; Melanocortin 4 receptor pathway dysfunction in obesity: Patient stratification aimed at MC4R agonist treatment. J Clin Endocrinol Metab 2018,103(7),2601-2612","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.nut.2019.06.027","volume":"\u2022","author":"Crovesy L.","year":"2019","unstructured":"Crovesy L.; Rosado E.L.; Interaction between genes involved in energy intake regulation and diet in obesity. Nutrition 2019,\u2022,67-68110547","journal-title":"Nutrition"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/nn.4202","volume":"19","author":"Krashes M.J.","year":"2016","unstructured":"Krashes M.J.; Lowell B.B.; Garfield A.S.; Melanocortin-4 receptor\u2013regulated energy homeostasis. Nat Neurosci 2016,19(2),206-219","journal-title":"Nat Neurosci"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ejphar.2013.04.060","volume":"719","author":"Mul J.D.","year":"2013","unstructured":"Mul J.D.; Spruijt B.M.; Brakkee J.H.; Adan R.A.H.; Melanocortin MC4 receptor-mediated feeding and grooming in rodents. Eur J Pharmacol 2013,719(1-3),192-201","journal-title":"Eur J Pharmacol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1517\/13543784.2014.934805","volume":"23","author":"&#xDC;ckert S.","year":"2014","unstructured":"&#xDC;ckert S.; Bannowsky A.; Albrecht K.; Kuczyk M.A.; Melanocortin receptor agonists in the treatment of male and female sexual dysfunctions: Results from basic research and clinical studies. Expert Opin Investig Drugs 2014,23(11),1477-1483","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1097\/AOG.0000000000003500","volume":"134","author":"Kingsberg S.A.","year":"2019","unstructured":"Kingsberg S.A.; Clayton A.H.; Portman D.; Bremelanotide for the treatment of hypoactive sexual desire disorder. Obstet Gynecol 2019,134(5),899-908","journal-title":"Obstet Gynecol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1210\/en.2014-1788","volume":"156","author":"Faulkner L.D.","year":"2015","unstructured":"Faulkner L.D.; Dowling A.R.; Stuart R.C.; Nillni E.A.; Hill J.W.; Reduced melanocortin production causes sexual dysfunction in male mice with POMC neuronal insulin and leptin insensitivity. Endocrinology 2015,156(4),1372-1385","journal-title":"Endocrinology"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.2174\/156802607780906681","volume":"7","author":"Carl S.","year":"2007","unstructured":"Carl S.; Sharma S.D.; Earle D.C.; Spana C.; Hallam T.J.; Melanocortins in the treatment of male and female sexual dysfunction. Curr Top Med Chem 2007,7(11),1137-1144","journal-title":"Curr Top Med Chem"}],"container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389450124666221108143006","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/210744\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389450124666221108143006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T04:41:45Z","timestamp":1680151305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/210744\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389450124666221108143006","relation":{},"ISSN":["1389-4501"],"issn-type":[{"type":"print","value":"1389-4501"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-05-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}